Virocomb 150 mg/300 mg Tablet
By Virocomb
Rx
60 Tablet in a Bottle

Composition
Lamivudine(150mg) + Zidovudine(300mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
July, 2026

liver
When taking Virocomb 150 mg/300 mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is highly recommended to consult your doctor before starting or continuing treatment with Virocomb 150 mg/300 mg Tablet. If you have moderate to severe liver disease, it is advised not to use this medication. Prior medical advice is essential to ensure the safety and efficacy of Virocomb 150 mg/300 mg Tablet in individuals with liver conditions.

kidney
Virocomb 150 mg/300 mg Tablet should be approached with caution for individuals with kidney disease. Adjusting the dose may be necessary, so it's advisable to consult your doctor first.

alcohol
When taking Virocomb 150 mg/300 mg Tablet, be cautious when drinking alcohol. It is recommended to speak with your doctor about alcohol consumption.

driving
When taking Virocomb 150 mg/300 mg Tablet, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Virocomb 150 mg/300 mg Tablet should be avoided during pregnancy as it may be harmful to the developing baby based on animal studies. Consult your doctor for a thorough evaluation of potential risks and benefits before using this medication.

breastfeeding
During breastfeeding, Virocomb 150 mg/300 mg Tablet is considered safe to use based on limited human data indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹1325.69
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025